Infusion site extravasation: Which Medications Cause It? (5,112 Reports Across 182 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Infusion site extravasation has been reported as an adverse event with 182 different drugs in the FDA's FAERS database, with 5,112 total reports. 113 of these reports resulted in death.The drugs most commonly associated with Infusion site extravasation are HUMAN IMMUNOGLOBULIN G, INFLIXIMAB, and INFLIXIMAB-DYYB.
5,112
Total Reports
182
Drugs Involved
113
Deaths
1,014
Hospitalizations
51.8 yrs
Average Patient Age
61.6% / 38.4%
Female / Male
Which Drugs Cause Infusion site extravasation Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| HUMAN IMMUNOGLOBULIN G | 822 | 1.2% | 14 | 140 | 0 |
| INFLIXIMAB | 435 | 0.3% | 9 | 64 | 1 |
| INFLIXIMAB-DYYB | 328 | 1.3% | 11 | 107 | 2 |
| TREPROSTINIL | 256 | 0.3% | 3 | 44 | 3 |
| VEDOLIZUMAB | 199 | 0.3% | 5 | 56 | 1 |
| HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | 185 | 4.2% | 5 | 30 | 0 |
| REMDESIVIR | 144 | 1.4% | 2 | 2 | 0 |
| FERRIC CARBOXYMALTOSE | 118 | 1.5% | 3 | 9 | 2 |
| RITUXIMAB | 82 | 0.1% | 9 | 33 | 1 |
| NATALIZUMAB | 70 | 0.1% | 0 | 10 | 1 |
| ECULIZUMAB | 59 | 0.1% | 0 | 10 | 1 |
| AGALSIDASE BETA | 58 | 0.9% | 0 | 7 | 0 |
| ALEMTUZUMAB | 57 | 0.4% | 1 | 12 | 2 |
| CARFILZOMIB | 52 | 0.2% | 1 | 11 | 1 |
| ACYCLOVIR | 51 | 0.4% | 0 | 16 | 0 |
| ALPHA.1-PROTEINASE INHIBITOR HUMAN | 47 | 0.7% | 0 | 14 | 0 |
| ZOLEDRONIC ACID | 47 | 0.1% | 1 | 4 | 1 |
| BAMLANIVIMAB | 45 | 0.9% | 0 | 3 | 0 |
| FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE | 45 | 4.0% | 0 | 2 | 0 |
| PATISIRAN | 45 | 1.7% | 0 | 27 | 0 |